Assembly Biosciences (ASMB) Assets (2010 - 2026)

Assembly Biosciences' Assets history runs 17 years deep, the most recent figure standing at $235.5 million for Q1 2026.

• On a quarterly basis, Assets rose 137.85% year-over-year to $235.5 million in Q1 2026; TTM through Mar 2026 was $235.5 million, a 137.85% increase from a year earlier, with the FY2025 full-year figure at $257.6 million, up 116.16% from the prior year.
• Assets fell to $235.5 million in Q1 2026 per ASMB's latest filing, from $257.6 million in the prior quarter.
• Across five years, Assets topped out at $257.6 million in Q4 2025 and bottomed at $51.6 million in Q3 2023.
• The 5-year median for Assets is $119.2 million (2024), against an average of $131.5 million.
• Across the five-year window, Assets sank 57.51% in 2023 and surged 139.37% in 2025, its largest moves.
• Year by year, Assets stood at $101.8 million in 2022, then soared by 34.41% to $136.8 million in 2023, then decreased by 12.9% to $119.2 million in 2024, then soared by 116.16% to $257.6 million in 2025, then retreated by 8.57% to $235.5 million in 2026.
• Per Business Quant, the three latest ASMB Assets figures stand at $235.5 million (Q1 2026), $257.6 million (Q4 2025), and $240.0 million (Q3 2025).